Expansion1 Aug 2026, 07:00 pm
Jeevan Scientific gets CDSCO approval to increase bed capacity
AI Summary
Jeevan Scientific Technology Ltd announced that the Central Drugs Standard Control Organization (CDSCO) has approved an increase in bed capacity at its Bioavailability/Bioequivalence (BA/BE) Study Centre in Hyderabad. The capacity has been enhanced from 132 beds and 6 ICU beds to 156 beds and 8 ICU beds. This approval follows a successful regulatory inspection and the company's application for enhancement. The increased capacity is expected to strengthen the company's clinical research infrastructure, improve operational capabilities, and allow for a higher volume of BA/BE studies, supporting future business growth.
Key Highlights
- CDSCO approves increased bed capacity at Jeevan Scientific's BA/BE Study Centre.
- Capacity increases from 132 beds/6 ICU to 156 beds/8 ICU.
- Enhancement expected to boost clinical research infrastructure and operational capabilities.
- Aims to undertake higher volume of BA/BE studies for future business growth.
Price Impact
More from JSTL